Efficacy and safety of triplet chemotherapy plus anti-EGFR agents in metastatic colorectal cancer: a systematic review and meta-analysis

Efficacy and safety of triplet chemotherapy plus anti-EGFR agents in metastatic colorectal cancer: a systematic review and meta-analysis

Abstract Background To date, the optimal treatment for potentially resectable metastatic colorectal cancer (mCRC) patients has yet to be determined. Encouraging results have been reported in studies exploring the efficacy of triplet chemotherapy plus anti-epidermal growth factor receptor (anti-EGFR)...

Full description

Bibliographic Details
Main Authors: Qian Wu, Huan Wang, Suqin Zhang, Yifei Zeng, Wei Yang, Wenjun Pan, Guodai Hong, Wenbin Gao
Format: Article
Language:English
Published: BMC 2022-08-01
Series:World Journal of Surgical Oncology
Subjects:
Metastatic colorectal cancer
Anti-EGFR
Triplet chemotherapy
Cetuximab
Panitumumab
Online Access:https://doi.org/10.1186/s12957-022-02707-x

Internet

https://doi.org/10.1186/s12957-022-02707-x

Similar Items